Abeona Therapeutics Inc.
ABEO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$5,161 | $108,833 | -$12,029 | -$9,293 |
| Dep. & Amort. | $888 | $768 | $815 | $776 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $2,830 | $2,701 | $1,955 |
| Change in WC | -$17,025 | $15,653 | -$3,422 | -$3,836 |
| Other Non-Cash | $111 | -$146,868 | -$6,467 | -$6,161 |
| Operating Cash Flow | -$21,187 | -$18,784 | -$18,402 | -$16,559 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2,520 | -$2,901 | -$1,401 | -$606 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$100,351 | -$19,854 | -$48,645 | -$10,483 |
| Inv. Sales/Matur. | $38,244 | $26,277 | $54,259 | $29,965 |
| Other Inv. Act. | $0 | $152,366 | $0 | $0 |
| Investing Cash Flow | -$64,627 | $155,888 | $4,213 | $18,876 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $5,163 | $10,501 | $6,799 | $5,513 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$6 | -$31 | -$199 |
| Financing Cash Flow | $5,163 | $10,495 | $6,768 | $5,314 |
| Forex Effect | -$0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$80,651 | $147,599 | -$7,421 | $7,631 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $163,873 | $16,274 | $23,695 | $16,064 |
| End Cash | $83,222 | $163,873 | $16,274 | $23,695 |
| Free Cash Flow | -$23,707 | -$21,685 | -$19,803 | -$17,165 |